Skip to main content

Table 2 Summary of HPV4 vaccine efficacy studies in men [5658]

From: Towards the eradication of HPV infection through universal specific vaccination

  Giuliano Palefsky Goldstone
Population Per-protocol Per-protocol Per-protocol*
  (16-26 years) (16-26 years) (16-26 years)
External genital lesions 90.4%   
  (95% CI: 69.2-98.1)   
Anal intraepithelial neoplasia   77.5% 91.7%
   (95% CI: 39.6-93.3) (95% CI: 44.6-99.8)
Condylomata acuminata 89.4%   
  (95% CI: 65.5-97.9)   
  1. * Post-hoc analysis.